N498 - EASD 2025 - SURPASS-CVOT: Tirzepatida mostra segurança cardiovascular e benefício renal em estudo histórico! - Ruy Lyra, Fernando Valente e Luciano Albuquerque

from SBD · host SBD

N498 - EASD 2025 - SURPASS-CVOT: Tirzepatida mostra segurança cardiovascular e benefício renal em estudo histórico! - Ruy Lyra, Fernando Valente e Luciano Albuquerque by SBD

Episode metadata supplied by the publisher feed · Published Dec 10, 2025

Embed this episode

Attribution link and audio player

Ready to play

N498 - EASD 2025 - SURPASS-CVOT: Tirzepatida mostra segurança cardiovascular e benefício renal em estudo histórico! - Ruy Lyra, Fernando Valente e Luciano Albuquerque

0:00 4:21

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

SBDcast SBDcast

Frequently Asked Questions

How long is this episode of SBD?

This episode is 4 minutes long.

When was this SBD episode published?

This episode was published on December 10, 2025.

Can I download this SBD episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!